Mark K. Oki

Insider Reports History

Entity
Individual
Location
C/O Alexza Pharmaceuticals Inc, 2091 Stierlin Court, Mountain View, CA
Signature
/s/ Mark K. Oki
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark K. Oki:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AYTU BIOPHARMA, INC Chief Financial Officer Employee Stock Option (Right to Buy) 13K Aug 11, 2023 Direct

Insider Reports Filed by Mark K. Oki

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AYTU AYTU BIOPHARMA, INC Aug 11, 2023 1 $0 4 Aug 15, 2023 Chief Financial Officer
AYTU AYTU BIOPHARMA, INC Nov 18, 2022 1 $20.7K 4/A Nov 28, 2022 Chief Financial Officer
AYTU AYTU BIOPHARMA, INC Jan 17, 2022 1 $0 4 Jan 19, 2022 Chief Financial Officer
AYTU AYTU BIOPHARMA, INC Jan 17, 2022 0 $0 3 Jan 19, 2022 Chief Financial Officer